Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2010 Jan 22;2854:2351-60. doi: 10.1074/jbc.M109.055764.
Show Gene links
Show Anatomy links
Mechanism of action of an imidopiperidine inhibitor of human polynucleotide kinase/phosphatase.
Freschauf GK
,
Mani RS
,
Mereniuk TR
,
Fanta M
,
Virgen CA
,
Dianov GL
,
Grassot JM
,
Hall DG
,
Weinfeld M
.
???displayArticle.abstract???
The small molecule, 2-(1-hydroxyundecyl)-1-(4-nitrophenylamino)-6-phenyl-6,7a-dihydro-1H-pyrrolo[3,4-b]pyridine-5,7(2H,4aH)-dione (A12B4C3), is a potent inhibitor of the phosphatase activity of human polynucleotide kinase/phosphatase (PNKP) in vitro. Kinetic analysis revealed that A12B4C3 acts as a noncompetitive inhibitor, and this was confirmed by fluorescence quenching, which showed that the inhibitor can form a ternary complex with PNKP and a DNA substrate, i.e. A12B4C3 does not prevent DNA from binding to the phosphatase DNA binding site. Conformational analysis using circular dichroism, UV difference spectroscopy, and fluorescence resonance energy transfer all indicate that A12B4C3 disrupts the secondary structure of PNKP. Investigation of the potential site of binding of A12B4C3 to PNKP using site-directed mutagenesis pointed to interaction between Trp(402) of PNKP and the inhibitor. Cellular studies revealed that A12B4C3 sensitizes A549 human lung cancer cells to the topoisomerase I poison, camptothecin, but not the topoisomerase II poison, etoposide, in a manner similar to small interfering RNA against PNKP. A12B4C3 also inhibits the repair of DNA single and double strand breaks following exposure of cells to ionizing radiation, but does not inhibit two other key strand-break repair enzymes, DNA polymerase beta or DNA ligase III, providing additional evidence that PNKP is the cellular target of the inhibitor.
Bernstein,
The molecular architecture of the mammalian DNA repair enzyme, polynucleotide kinase.
2005, Pubmed
Bernstein,
The molecular architecture of the mammalian DNA repair enzyme, polynucleotide kinase.
2005,
Pubmed
Bernstein,
Polynucleotide kinase as a potential target for enhancing cytotoxicity by ionizing radiation and topoisomerase I inhibitors.
2008,
Pubmed
Breslin,
DNA 3'-phosphatase activity is critical for rapid global rates of single-strand break repair following oxidative stress.
2009,
Pubmed
,
Xenbase
Chappell,
Involvement of human polynucleotide kinase in double-strand break repair by non-homologous end joining.
2002,
Pubmed
Chen,
Determination of the helix and beta form of proteins in aqueous solution by circular dichroism.
1974,
Pubmed
Donovan,
Ultraviolet difference spectroscopy--new techniques and applications.
1973,
Pubmed
Freschauf,
Identification of a small molecule inhibitor of the human DNA repair enzyme polynucleotide kinase/phosphatase.
2009,
Pubmed
Ismail,
SU11752 inhibits the DNA-dependent protein kinase and DNA double-strand break repair resulting in ionizing radiation sensitization.
2004,
Pubmed
Jilani,
Molecular cloning of the human gene, PNKP, encoding a polynucleotide kinase 3'-phosphatase and evidence for its role in repair of DNA strand breaks caused by oxidative damage.
1999,
Pubmed
Karimi-Busheri,
Molecular characterization of a human DNA kinase.
1999,
Pubmed
Koch,
Xrcc4 physically links DNA end processing by polynucleotide kinase to DNA ligation by DNA ligase IV.
2004,
Pubmed
Mani,
Spectroscopic studies of DNA and ATP binding to human polynucleotide kinase: evidence for a ternary complex.
2003,
Pubmed
Mani,
Spectral studies on the calcium binding properties of bovine brain S-100b protein.
1983,
Pubmed
Mani,
Biophysical characterization of human XRCC1 and its binding to damaged and undamaged DNA.
2004,
Pubmed
Mani,
XRCC1 stimulates polynucleotide kinase by enhancing its damage discrimination and displacement from DNA repair intermediates.
2007,
Pubmed
Mani,
Physical properties of human polynucleotide kinase: hydrodynamic and spectroscopic studies.
2001,
Pubmed
Nitiss,
Mechanisms of cell killing by drugs that trap covalent complexes between DNA topoisomerases and DNA.
1996,
Pubmed
O'Connor,
Targeted cancer therapies based on the inhibition of DNA strand break repair.
2007,
Pubmed
Plo,
Association of XRCC1 and tyrosyl DNA phosphodiesterase (Tdp1) for the repair of topoisomerase I-mediated DNA lesions.
2003,
Pubmed
Rasouli-Nia,
Stable down-regulation of human polynucleotide kinase enhances spontaneous mutation frequency and sensitizes cells to genotoxic agents.
2004,
Pubmed
Selvin,
Fluorescence resonance energy transfer.
1995,
Pubmed
Ulaczyk-Lesanko,
Optimization of three- and four-component reactions for polysubstituted piperidines: application to the synthesis and preliminary biological screening of a prototype library.
2007,
Pubmed
Wells,
Synthesis and structure-activity relationships of novel pyrrolocarbazole lactam analogs as potent and cell-permeable inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).
2006,
Pubmed
Whitehouse,
XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair.
2001,
Pubmed
,
Xenbase
Wiederhold,
AP endonuclease-independent DNA base excision repair in human cells.
2004,
Pubmed
,
Xenbase
